A total of 225 patients were randomized ( 2:2:1 ) to 2 different itolizumab arms ( A or B ; A = 4-week loading dose of 0.4 mg/kg/wk followed by 1.6 mg/kg every 2 weeks ; B = 1.6 / mg every 2 weeks ) or placebo .